Ardelyx Inc Receivables Turnover Ratio (ARDX), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Ardelyx inc   (NASDAQ: ARDX)
 

Ardelyx Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Ardelyx Inc 's ability to collect accounts receivable sequentially worsen to 5.44, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Ardelyx Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 67 days, from 63 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 314 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2338, from overall ranking in the first quarter 2026 at 2415.

What is Receivable Turnover Ratio?
What is Ardelyx Inc Selling?


What is Receivable Turnover Ratio?





ARDX Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 60.43 % 78.28 % 24.51 % 44.02 % 67.97 %
Y / Y Revenue Change 23.77 % 27.47 % 7.82 % 12.3 % 33.38 %
Receivable Turnover Ratio (TTM) 5.44 5.82 6.33 6.55 7.02
ARDX's Total Ranking # 2338 # 2415 # 2117 # 1954 # 1853
Accounts Receivable average collection period days 67 63 58 56 52
Seq. Receivable Change 21.14 % 15.3 % -6.22 % 22.47 % 34.62 %
Seq. Revenue Change 27.95 % -24.55 % 13.49 % 12.97 % 31.77 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 92
Healthcare Sector # 315
Overall Market # 2338

Receivable Turnover Ratio Statistics
High Average Low
36.98 9.11 1.92
(Dec 31 2018)   (Jun 30 2022)






Financial Statements
Ardelyx Inc 's Accounts Receivable $ 100 Millions Visit ARDX's Balance sheet
Ardelyx Inc 's Sales TTM $ 451 Millions Visit ARDX's Income Statement
Sources of ARDX's Revenues Visit ARDX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ARDX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ARDX's Growth Rates ARDX's Roa ARDX's Inventory Turnover Ratio ARDX's Dividend Comparisons
ARDX's Profitability Ratios ARDX's Roi ARDX's Asset Turnover Ratio ARDX's Dividend Growth
ARDX's Valuation Ratios ARDX's Roe ARDX's Financial Strength Ratios ARDX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.82 $ 8.855  Millions$ 0.749  Millions
Marpai Inc  11.71 $ 16.635  Millions$ 1.420  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Nrc Health  11.35 $ 139.996  Millions$ 12.337  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Premier Air Charter Holdings Inc   10.66 $ 31.562  Millions$ 2.961  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Lifeloc Technologies Inc   10.48 $ 9.269  Millions$ 0.884  Millions
Immucell Corporation  10.29 $ 29.777  Millions$ 2.893  Millions
Addus Homecare Corp  10.23 $ 1,475.610  Millions$ 144.195  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions
Radnet Inc   10.11 $ 2,268.932  Millions$ 224.447  Millions
Utah Medical Products Inc  9.88 $ 35.679  Millions$ 3.612  Millions
Lensar Inc   9.75 $ 60.264  Millions$ 6.184  Millions
Biolife Solutions Inc   9.67 $ 102.718  Millions$ 10.626  Millions
Encompass Health Corporation  9.57 $ 6,206.100  Millions$ 648.325  Millions
The Oncology Institute Inc   9.57 $ 587.244  Millions$ 61.364  Millions
Alumis inc   9.44 $ 7.398  Millions$ 0.784  Millions
Enanta Pharmaceuticals Inc  9.29 $ 65.258  Millions$ 7.027  Millions
Neuronetics Inc   9.24 $ 154.594  Millions$ 16.732  Millions
Harmony Biosciences Holdings inc   9.22 $ 960.191  Millions$ 104.164  Millions
Pavmed Inc   9.16 $ 0.126  Millions$ 0.014  Millions
Ardent Health Inc   9.16 $ 6,405.940  Millions$ 699.363  Millions
Bioaffinity Technologies Inc   9.11 $ 5.901  Millions$ 0.648  Millions
Sunshine Biopharma Inc   9.03 $ 35.347  Millions$ 3.916  Millions

Date modified: 2026-09-06T18:35:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.